Menu
GeneBe

rs138688940

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_032638.5(GATA2):c.657G>T(p.Glu219Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. E219E) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

GATA2
NM_032638.5 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -1.18
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08317363).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GATA2NM_001145661.2 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 4/7 ENST00000487848.6
GATA2NM_032638.5 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 3/6 ENST00000341105.7
GATA2NM_001145662.1 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 3/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GATA2ENST00000341105.7 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 3/61 NM_032638.5 P1P23769-1
GATA2ENST00000487848.6 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 4/71 NM_001145661.2 P1P23769-1
GATA2ENST00000430265.6 linkuse as main transcriptc.657G>T p.Glu219Asp missense_variant 3/61 P23769-2
GATA2ENST00000696466.1 linkuse as main transcriptc.939G>T p.Glu313Asp missense_variant 5/8

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 04, 2023This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 219 of the GATA2 protein (p.Glu219Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GATA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1052524). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GATA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 17, 2022Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.044
BayesDel_addAF
Benign
-0.015
T
BayesDel_noAF
Benign
-0.26
Cadd
Benign
6.9
Dann
Benign
0.86
DEOGEN2
Benign
0.28
T;.;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.65
D
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.083
T;T;T
MetaSVM
Benign
-0.35
T
MutationAssessor
Benign
0.76
N;N;N
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.26
N;N;N
REVEL
Uncertain
0.33
Sift
Benign
0.47
T;T;T
Sift4G
Benign
0.76
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.19
MutPred
0.18
Gain of glycosylation at S220 (P = 0.0114);Gain of glycosylation at S220 (P = 0.0114);Gain of glycosylation at S220 (P = 0.0114);
MVP
0.45
MPC
0.48
ClinPred
0.12
T
GERP RS
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.055
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-128204784; COSMIC: COSV100350963; COSMIC: COSV100350963; API